Ilex Medical Ltd (TLV: ILX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
7,483.00
-440.00 (-5.55%)
Dec 19, 2024, 5:24 PM IDT

Ilex Medical Cash Flow Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
54.8150.89102.12197.48120.6260.26
Upgrade
Depreciation & Amortization
34.3233.5236.3250.4939.8937.47
Upgrade
Other Amortization
14.2114.2113.72---
Upgrade
Loss (Gain) From Sale of Assets
0.3-0.26-21.960.010.36-1.05
Upgrade
Loss (Gain) From Sale of Investments
-5.22-4.122.84-3.680.71-2.52
Upgrade
Loss (Gain) on Equity Investments
6.484.012.690.26--
Upgrade
Stock-Based Compensation
-----0.02
Upgrade
Other Operating Activities
4.5-15.53-30.7725.162.555.69
Upgrade
Change in Accounts Receivable
-2.7-56-23.921.28-26.248.52
Upgrade
Change in Inventory
13.51-14.13-27.7120.89-47.87-13.77
Upgrade
Change in Accounts Payable
-11.0232.4910.6-20.2246.93-5.07
Upgrade
Change in Unearned Revenue
24.7696.58----
Upgrade
Change in Other Net Operating Assets
-20.08-61.215.79-2145.44-4.84
Upgrade
Operating Cash Flow
113.8880.4369.74270.68182.484.89
Upgrade
Operating Cash Flow Growth
251.48%15.33%-74.24%48.39%114.88%44.86%
Upgrade
Capital Expenditures
-31.03-48.77-26.14-40.94-44.3-29.91
Upgrade
Sale of Property, Plant & Equipment
0.220.170.081.060.025.02
Upgrade
Cash Acquisitions
---10.51---
Upgrade
Sale (Purchase) of Intangibles
-4.07-3.39-2.22-1.7-2.08-1.35
Upgrade
Investment in Securities
7.45-38.68-50.78-38.121.66-0.53
Upgrade
Other Investing Activities
---7.07-2.78--
Upgrade
Investing Cash Flow
-27.43-90.68-53.64-82.45-24.71-26.77
Upgrade
Short-Term Debt Issued
-----0.23
Upgrade
Long-Term Debt Issued
-----1.66
Upgrade
Total Debt Issued
-----1.89
Upgrade
Short-Term Debt Repaid
----0.22-15.74-
Upgrade
Long-Term Debt Repaid
--13.56-13.71-26.56-29.52-31.1
Upgrade
Total Debt Repaid
-13.33-13.56-13.71-26.77-45.26-31.1
Upgrade
Net Debt Issued (Repaid)
-13.33-13.56-13.71-26.77-45.26-29.22
Upgrade
Repurchase of Common Stock
--5.72-3.49---
Upgrade
Common Dividends Paid
-15.27-21.44-60-60--25
Upgrade
Other Financing Activities
---0.1-0.01-3.48-8.61
Upgrade
Financing Cash Flow
-28.59-40.72-77.3-86.78-48.74-62.83
Upgrade
Foreign Exchange Rate Adjustments
-1.43-1.612.92-2.040.45-0.65
Upgrade
Net Cash Flow
56.42-52.57-58.2899.41109.41-5.36
Upgrade
Free Cash Flow
82.8531.6643.6229.73138.154.98
Upgrade
Free Cash Flow Growth
--27.38%-81.02%66.35%151.20%59.20%
Upgrade
Free Cash Flow Margin
8.43%3.40%5.00%21.65%14.59%8.67%
Upgrade
Free Cash Flow Per Share
7.402.833.8720.3612.945.48
Upgrade
Cash Interest Paid
2.431.81.611.932.092.29
Upgrade
Cash Income Tax Paid
18.5434.3176.7730.7928.5319.93
Upgrade
Levered Free Cash Flow
89.4733.8731.28168.57110.935.55
Upgrade
Unlevered Free Cash Flow
89.4734.9932.28169.8112.3637.18
Upgrade
Change in Net Working Capital
-32.926.0976.2-8.11-27.2916.39
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.